🇺🇸 FDA
Patent

US 9630990

Inhibition of pulmonary fibrosis with nutlin-3A and peptides

granted A61KA61K31/497A61K38/00

Quick answer

US patent 9630990 (Inhibition of pulmonary fibrosis with nutlin-3A and peptides) held by The Board of Regents of the University of Texas System expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/497, A61K38/00, A61K38/08, A61K38/177